Grow Together” initiative involves Rubicon backing, with both capital and strategic support, seed and early-stage ventures founded by entrepreneurs and innovators in not only the traditional pharmaceutical domain but also in allied domains involving application of emerging technologies like AI, continuous manufacturing and big data in the pharmaceutical industry, to achieve Rubicon’s key goals of Innovation, Quality and Care. Rubicon invites such entrepreneurs and innovators from across the globe, who are looking for financing and partnerships, to email their proposals to The proposals will be confidentially reviewed by the CEO’s office to evaluate their fit into the company’s stringent science criteria.